|
| Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here |
 |
| Web Version |
Share with a colleague
| View Digital Edition | Subscribe |
With COVID-19 among us, printed copies being sent to offices that are closed are possibly not being read/received right now, so we’re going to be adding all of our print subscribers (with email) to our digital distribution lists, in order to attempt to get their issues to them (some are unsubscribed/bad emails, so we won’t hit everyone). That being said, please work with the enews production team to include a note like the below in each of the next issue alert templates (feel free to edit & please pass on to anyone I may have missed):
Notice to our subscribers currently receiving printed copies of our magazine: Due to COVID-19, we are delivering each issue to you via email. Please note your issues will also still be delivered to you via postal mail, and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form.
|
In our April issue of Pharmaceutical Executive
FEATURES
Cover Feature
2020 HBA Woman of the Year: Sandra Horning
Elaine Quilici
For Sandra Horning, this year's Healthcare Businesswomen’s Association Woman of the Year, harnessing the patient experience has been the driving force in a career-spanning—and service-focused—mission to fight disease and accelerate the delivery of new medicines.
Download the digital issue
|
ADVERTISEMENT
Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience Goals
Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT
Register Now |
Diversity & Inclusion
Doubling Down on D&I
Julian Upton
Recognizing that diversity and inclusion is no longer simply a “nice to have,” pharma has boosted efforts in this area. But just how far are new industry initiatives moving the needle on D&I?
Download the digital issue |
ADVERTISEMENT
The Evolution of End of Study Media: From CDs to the Cloud
Thursday, May 7, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now |
Pricing
Payer Perspectives on Gene Therapy Reimbursement
Jane F. Barlow, Matt W. Courtney, Mark Trusheim
A follow-up survey of clinical and financial health plan leaders uncovers evolving approaches and views on the management of high-cost, curative-intended treatments with one-time administration.
Download the digital issue |
Prescribing Patterns
How to Get Ahead of the Trends
Janardhan Vellore and Daniel Wetherill
The key to success in a hypercompetitive marketplace is to create targeting plans that get ahead of tomorrow’s prescriptions.
Download the digital issue |
ALSO IN THIS ISSUE
COVID-19 Ripple Effects for Pharma
Lisa Henderson
Speculating the downstream impact on industry practices is just that right now—speculation. What is sure is some things will never be the same, and some things could even get better …Read more
Covid-19 Pandemic Thrusts Biopharma R&D to Forefront
Jill Wechsler
Emergency funds for research, public health, and economic disaster raise access issues …Read more
There’s No Easing the Price-vs.-Value Debate
Reflector
With coronavirus a stark backdrop, European initiative pushes for “fair” drug prices to spur investment in pharma innovation …Read more
|
|
|
|
Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.
Click here to contact the Pharmaceutical Executive sales team. |
 |
|
